C. Hu
Impact in
- Molecular Medicine top 2%
- Curcumin's Biomedical Applications
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Natural product bioactivities and synthesis 8
- FOXO transcription factor regulation 5
- Pharmacology 12
- Pharmacological Effects of Natural Compounds 9
- Co-authors
- Shiming Yang (16 shared papers)Yufeng Xiao (12 shared papers)Zhimin Chen (19 shared papers)Rui Xie (8 shared papers)Lingying Yu (12 shared papers)Bo–Sheng Li (6 shared papers)Shiming Yang (10 shared papers)Mingyue Ao (2 shared papers)
- Journals
- Cancer Letters (6 papers)Oncotarget (3 papers)Cell Communication and Signaling (3 papers)Bioorganic Chemistry (2 papers)Advanced Science (2 papers)
- Partner nations
- ChinaUnited StatesNigeria
In The Last Decade
C. Hu
80 papers receiving 3.6k citations
C. Hu's Hit Papers
Peers
Comparison fields: 5 of 121
- Molecular Medicine 288
- Cancer Research 759
- Molecular Biology 1.8k
- Complementary and alternative medicine 192
- Pharmacology 186
Countries citing papers authored by C. Hu
This map shows the geographic impact of C. Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Hu more than expected).
Fields of papers citing papers by C. Hu
This network shows the impact of papers produced by C. Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Hu. The network helps show where C. Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Anti-Inflammatory Effects of Curcumin in the Inflammatory Diseases: Status, Limitations and Countermeasures Hit paper breakdown → | 2021 | 547 |
| 2 | Regulation of the master regulator FOXM1 in cancer Hit paper breakdown → | 2018 | 300 |
| 3 | 2015 | 185 | |
| 4 | 2021 | 147 | |
| 5 | 2020 | 146 | |
| 6 | 2016 | 141 | |
| 7 | 2015 | 137 | |
| 8 | 2015 | 131 | |
| 9 | 2018 | 129 | |
| 10 | 2013 | 128 | |
| 11 | 2018 | 117 | |
| 12 | 2015 | 103 | |
| 13 | 2015 | 91 | |
| 14 | 2015 | 74 | |
| 15 | 2015 | 71 | |
| 16 | 2017 | 66 | |
| 17 | 2013 | 55 | |
| 18 | 2010 | 52 | |
| 19 | 2016 | 50 | |
| 20 | 2017 | 44 |
About C. Hu
C. Hu is a scholar working on Molecular Biology, Pharmacology, Oncology, Complementary and alternative medicine and Surgery, having authored 81 papers that have together received 3.7k indexed citations. Recurring topics across this work include Pharmacological Effects of Natural Compounds (9 papers), Natural product bioactivities and synthesis (8 papers), Helicobacter pylori-related gastroenterology studies (5 papers), Telomeres, Telomerase, and Senescence (5 papers), Cancer-related molecular mechanisms research (5 papers), FOXO transcription factor regulation (5 papers), Cancer Cells and Metastasis (4 papers) and Traditional Chinese Medicine Analysis (4 papers). The work is most often cited by research in Molecular Medicine (288 citations), Cancer Research (759 citations), Molecular Biology (1.8k citations), Complementary and alternative medicine (192 citations) and Pharmacology (186 citations). C. Hu has collaborated with scholars based in China, United States and Nigeria. Frequent co-authors include Shiming Yang, Yufeng Xiao, Zhimin Chen, Rui Xie, Lingying Yu, Bo–Sheng Li, Shiming Yang, Mingyue Ao, Ying Peng and Bo Tang. Their work appears in journals such as Cancer Letters, Oncotarget, Cell Communication and Signaling, Bioorganic Chemistry and Advanced Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.